![Wendy Perrow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wendy Perrow
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Patricia Russo | F | 71 | 29 Jahre | |
Steven Altschuler | M | 70 |
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 5 Jahre |
Caroline Litchfield | F | 55 | 34 Jahre | |
Christine Thomas | F | 52 | 2 Jahre | |
Sapna R. Srivastava | M | 53 |
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 5 Jahre |
Dov Elefant | M | 56 | 2 Jahre | |
James Matteucci | M | - | 21 Jahre | |
Joshua Barer | M | - |
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | 6 Jahre |
Alistair Milnes | M | 51 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Robert P. Luciano | M | - | 23 Jahre | |
Richard Kogan | M | 81 | 21 Jahre | |
Kenneth Frazier | M | 69 | 30 Jahre | |
P. Vagelos | M | 94 | 19 Jahre | |
Bruce Peacock | M | 72 |
Alba Therapeutics Corp.
![]() Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | - |
Raymond Gilmartin | M | 82 | 2 Jahre | |
Fred Hassan | M | 78 | 6 Jahre | |
Jeffrey Church | M | 67 |
Alba Therapeutics Corp.
![]() Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | 3 Jahre |
David Anstice | M | 75 | 5 Jahre | |
Joseph Romanelli | M | 50 | 19 Jahre | |
Thomas Shenk | M | 77 | 11 Jahre | |
Donald S. Brooks | M | 88 | - | |
William Harrison | M | 80 | - | |
Richard Markham | M | 73 | 20 Jahre | |
Wendy Yarno | F | 68 | 9 Jahre | |
Marino Carol | F | - | 8 Jahre | |
John Adams | M | 62 | 8 Jahre | |
Ismail Kola | M | 67 | 4 Jahre | |
David Gionco | M | 63 | 3 Jahre | |
Anne Tatlock | F | 84 | - | |
Peter Wendell | M | 73 | 21 Jahre | |
Kevin M. Slawin | M | 63 |
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | - |
Larry G. Edwards | M | 52 | 15 Jahre | |
Gary Thompson | M | 67 | 12 Jahre | |
Laura Sepp-Lorenzino | M | 63 | 15 Jahre | |
Anne Morrissey | F | 57 | 2 Jahre | |
William B. Witte | M | 61 | 5 Jahre | |
John Dyett | M | 54 | 6 Jahre | |
Kimberly Murphy | F | 62 | 6 Jahre | |
Christine Bunt | F | - | 7 Jahre | |
Dorothy P. Bowers | F | - | - | |
Berta Strulovici | M | - | - | |
Eric Schadt | M | 59 | 8 Jahre | |
James Villalobos | M | 55 | - | |
Silvana Battaglia | F | 56 | 10 Jahre | |
Judith C. Seltz | F | 61 | 15 Jahre | |
Jens Renstrup | M | 59 | 8 Jahre | |
Joe Pedersen | M | - | 23 Jahre | |
Carole A. Sable | M | 62 | 12 Jahre | |
David A. Esposito | M | 55 | 13 Jahre | |
Jacob Harel | M | 69 | 13 Jahre | |
Arthur Santora | M | 73 | 28 Jahre | |
Simon D. Kelner | M | 51 | 13 Jahre | |
Juan Camilo Arjona Ferreira | M | 54 | 12 Jahre | |
Kevin J. Horgan | M | 64 | 8 Jahre | |
Kyu-Sung Lee | M | 64 | 10 Jahre | |
Zhi Sheng Chen | M | 52 | 5 Jahre | |
Lisa Escudero | F | 62 | 18 Jahre | |
Desiree Ralls-Morrison | F | 57 | 8 Jahre | |
Glenn Williams | M | - | 10 Jahre | |
James S. MacDonald | M | - | 17 Jahre | |
François Meurgey | M | - | - | |
Benito Munoz | M | 62 | 9 Jahre | |
Barbara Yanni | F | 69 | 13 Jahre | |
Ernesto Aycardi | M | 61 | 11 Jahre | |
Gregory S. Patrick | M | 72 | 14 Jahre | |
Jim Hinrichs | M | 56 | 5 Jahre | |
Nolan Sigal | M | 73 | 10 Jahre | |
Philippe Schaison | M | 62 | 7 Jahre | |
Barry Gumbiner | M | 68 | 6 Jahre | |
Mark E. McDonough | M | 59 | - | |
Timothy Proctor | M | 74 | 13 Jahre | |
Stefan Oschmann | M | 66 | 20 Jahre | |
James Christopher Scalet | M | 65 | 9 Jahre | |
Peter G. Ernster | M | 82 | 26 Jahre | |
Larry Bossidy | M | 89 | 14 Jahre | |
Joan Wainwright | F | 63 | 6 Jahre | |
Marcia Avedon | M | 62 | 4 Jahre | |
Stephen Gold | M | 65 | 2 Jahre | |
Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 Jahre | |
Robert Segal | M | 66 | - | |
George Morrow | M | 72 | 11 Jahre | |
Heidi Miller | M | 70 | 4 Jahre | |
Samuel O. Thier | M | 86 | 16 Jahre | |
Lars Kåre Viksmoen | M | 75 | 14 Jahre | |
Michael Atieh | M | 70 | 19 Jahre | |
Thomas J. Ouellette | M | - | 16 Jahre | |
Gary T. Shearman | M | - | 5 Jahre | |
Gerald J. Gallivan | M | - | - | |
Horace D. Nalle | M | - | - | |
Zofia E. Dziewanowska | M | 82 | - | |
Frank Verwiel | M | 61 | 4 Jahre | |
Jean-Michael Halfon | M | 72 | 2 Jahre | |
Abraham E. Cohen | M | 87 | 10 Jahre | |
Guy MacDonald | M | 65 | 22 Jahre | |
Ronald B. Moss | M | 64 | 1 Jahre | |
Jeffrey A. Peris | M | 77 | 25 Jahre | |
Vijay Samant | M | 77 | 23 Jahre | |
Margaret McGlynn | F | 64 | 11 Jahre | |
Michael Tarnow | M | 79 | 22 Jahre | |
Mark Bach | M | 67 | 17 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Wendy Perrow
- Persönliches Netzwerk